German healthcare group Fresenius SE & Co. KGaA (FRE.XE)
said Tuesday it intends to issue EUR200 million of senior unsecured
notes to fund the acquisition of hospitals from rival
Rhoen-Klinikum AG (RHK.XE).
MAIN FACTS:
-Fresenius plans to issue the notes with a maturity of 10
years.
-In early January, it had also placed EUR750 million senior
notes as a step to fund the announced acquisition.
-Fresenius Finance B.V., a wholly owned subsidiary of Fresenius,
will issue and offer the senior notes through a private placement
with institutional investors.
-Fresenius has applied to the Luxembourg Stock Exchange to admit
the senior notes to trading on its regulated market.
-Fresenius and Rhoen-Klinikum agreed on the sale of 43 hospitals
and 15 outpatient facilities for EUR3.07 billion in September,
while German antitrust authorities have asked to exclude three of
these hospitals from the deal.
-Write to the Frankfurt Bureau at
djnews.frankfurt@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
